The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsumoto, G.
Right arrow Articles by Penninger, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsumoto, G.
Right arrow Articles by Penninger, J. M.
The Journal of Immunology, 1998, 160: 5781-5789.
Copyright © 1998 by The American Association of Immunologists

Cooperation Between CD44 and LFA-1/CD11a Adhesion Receptors in Lymphokine-Activated Killer Cell Cytotoxicity

Goichi Matsumoto{dagger}, Mai P. Nghiem*, Naohito Nozaki{dagger}, Rudolf Schmits* and Josef M. Penninger1,*

* Amgen Institute, and Ontario Cancer Institute, Department of Medical Biophysics and Immunology, University of Toronto, Toronto, Ontario, Canada; and {dagger} Department of Oral Biochemistry, Kanagawa Dental College, Kanagawa, Japan

IL-2-activated NK cells exhibit cytotoxic activity against a wide variety of tumor cells in a non-MHC-restricted fashion and in the absence of prior sensitization. The molecular mechanisms that regulate the cytotoxicity and attachment of activated killer cells to tumor target cells are not known. We provide genetic evidence in CD44-/- and LFA-1-/- mice that the cell adhesion receptors LFA-1 and CD44 regulate the cytotoxic activity of IL-2-activated NK cells against a variety of different tumor cells. This defect in cytotoxicity was significantly enhanced in mice that carried a double mutation of both CD44 and LFA-1. In vitro differentiation, TNF-{alpha} and IFN-{gamma} production, and expression of the cytolytic effector molecules perforin and Fas-L were comparable among IL-2-activated NK cells from LFA-1-/-, CD44-/-, CD44-/-LFA-1-/-, and control mice. However, CD44-/-, LFA-1-/-, and CD44-/-LFA-1-/- IL-2-activated NK cells showed impaired binding and conjugate formation with target cells. We also show that hyaluronic acid is the principal ligand on tumor cells for CD44-mediated cytotoxicity of IL-2-activated NK cells. These results provide the first genetic evidence of the role of adhesion receptors in IL-2-activated NK killing. These data also indicate that distinct adhesion receptors cooperate to mediate binding between effector and target cells required for the initiation of "natural" cytotoxicity.




This article has been cited by other articles:


Home page
BloodHome page
Y. T. Bryceson, H.-G. Ljunggren, and E. O. Long
Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors
Blood, September 24, 2009; 114(13): 2657 - 2666.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
G. J. Jones, J. C. D. Wiseman, K. J. Marr, S. Wei, J. Y. Djeu, and C. H. Mody
In contrast to anti-tumor activity, YT cell and primary NK cell cytotoxicity for Cryptococcus neoformans bypasses LFA-1
Int. Immunol., April 1, 2009; 21(4): 423 - 432.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. M. Mace, S. J. Monkley, D. R. Critchley, and F. Takei
A Dual Role for Talin in NK Cell Cytotoxicity: Activation of LFA-1-Mediated Cell Adhesion and Polarization of NK Cells
J. Immunol., January 15, 2009; 182(2): 948 - 956.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. Banerjee, G. Feuer, and E. Barker
Human T-Cell Leukemia Virus Type 1 (HTLV-1) p12I Down-Modulates ICAM-1 and -2 and Reduces Adherence of Natural Killer Cells, Thereby Protecting HTLV-1-Infected Primary CD4+ T Cells from Autologous Natural Killer Cell-Mediated Cytotoxicity despite the Reduction of Major Histocompatibility Complex Class I Molecules on Infected Cells
J. Virol., September 15, 2007; 81(18): 9707 - 9717.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Back, A. Chalifour, L. Scarpellino, and W. Held
Stable masking by H-2Dd cis ligand limits Ly49A relocalization to the site of NK cell/target cell contact
PNAS, March 6, 2007; 104(10): 3978 - 3983.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. N. M. Nolte-'t Hoen, C. R. Almeida, N. R. Cohen, S. Nedvetzki, H. Yarwood, and D. M. Davis
Increased surveillance of cells in mitosis by human NK cells suggests a novel strategy for limiting tumor growth and viral replication
Blood, January 15, 2007; 109(2): 670 - 673.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
G. Suck, D. R. Branch, P. Aravena, M. Mathieson, S. Helke, and A. Keating
Constitutively polarized granules prime KHYG-1 NK cells
Int. Immunol., September 1, 2006; 18(9): 1347 - 1354.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
L. V. Fostel, J. Dluzniewska, Y. Shimizu, B. J. Burbach, and E. J. Peterson
ADAP is dispensable for NK cell development and function
Int. Immunol., August 1, 2006; 18(8): 1305 - 1314.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Guerau-de-Arellano, J. Alroy, D. Bullard, and B. T. Huber
Aggravated Lyme Carditis in CD11a-/- and CD11c-/- Mice
Infect. Immun., November 1, 2005; 73(11): 7637 - 7643.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
Y. T. Bryceson, M. E. March, D. F. Barber, H.-G. Ljunggren, and E. O. Long
Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells
J. Exp. Med., October 3, 2005; 202(7): 1001 - 1012.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. F. Barber, M. Faure, and E. O. Long
LFA-1 Contributes an Early Signal for NK Cell Cytotoxicity
J. Immunol., September 15, 2004; 173(6): 3653 - 3659.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
O. Stehling, V. Grau, and B. Steiniger
Monocyte cytotoxicity during acute kidney graft rejection in rats
Int. Immunol., January 1, 2004; 16(1): 101 - 110.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. J. McKallip, M. Fisher, Y. Do, A. K. Szakal, U. Gunthert, P. S. Nagarkatti, and M. Nagarkatti
Targeted Deletion of CD44v7 Exon Leads to Decreased Endothelial Cell Injury but Not Tumor Cell Killing Mediated by Interleukin-2-activated Cytolytic Lymphocytes
J. Biol. Chem., October 31, 2003; 278(44): 43818 - 43830.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Emoto, M. Miyamoto, Y. Emoto, I. Yoshizawa, V. Brinkmann, N. van Rooijen, and S. H. E. Kaufmann
Highly Biased Type 1 Immune Responses in Mice Deficient in LFA-1 in Listeria monocytogenes Infection Are Caused by Elevated IL-12 Production by Granulocytes
J. Immunol., October 15, 2003; 171(8): 3970 - 3976.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
B. Riteau, D. F. Barber, and E. O. Long
Vav1 Phosphorylation Is Induced by {beta}2 Integrin Engagement on Natural Killer Cells Upstream of Actin Cytoskeleton and Lipid Raft Reorganization
J. Exp. Med., August 4, 2003; 198(3): 469 - 474.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
M. Noutsias, M. Pauschinger, H.-P. Schultheiss, and U. Kuhl
Cytotoxic perforin+ and TIA-1+ infiltrates are associated with cell adhesion molecule expression in dilated cardiomyopathy
Eur J Heart Fail, August 1, 2003; 5(4): 469 - 479.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Zhao, H. Ohdan, J. O. Manilay, and M. Sykes
NK Cell Tolerance in Mixed Allogeneic Chimeras
J. Immunol., June 1, 2003; 170(11): 5398 - 5405.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
K. Shingu, C. Kruschinski, A. Luhrmann, K. Grote, T. Tschernig, S. von Horsten, and R. Pabst
Intratracheal Macrophage-Activating Lipopeptide-2 Reduces Metastasis in the Rat Lung
Am. J. Respir. Cell Mol. Biol., March 1, 2003; 28(3): 316 - 321.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Matsumoto, S. Tsunematsu, K.-i. Tsukinoki, Y. Ohmi, M. Iwamiya, A. Oliveira-dos-Santos, D. Tone, J. Shindo, and J. M. Penninger
Essential Role of the Adhesion Receptor LFA-1 for T Cell-Dependent Fulminant Hepatitis
J. Immunol., December 15, 2002; 169(12): 7087 - 7096.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
M. Noutsias, M. Pauschinger, H.-P. Schultheiss, and U. Kuhl
Advances in the immunohistological diagnosis of inflammatory cardiomyopathy
Eur. Heart J. Suppl., December 1, 2002; 4(suppl_I): I54 - I62.
[Abstract] [PDF]


Home page
J. Immunol.Home page
D. Bechard, A. Scherpereel, H. Hammad, T. Gentina, A. Tsicopoulos, M. Aumercier, J. Pestel, J.-P. Dessaint, A.-B. Tonnel, and P. Lassalle
Human Endothelial-Cell Specific Molecule-1 Binds Directly to the Integrin CD11a/CD18 (LFA-1) and Blocks Binding to Intercellular Adhesion Molecule-1
J. Immunol., September 15, 2001; 167(6): 3099 - 3106.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
N Foger, R Marhaba, and M Zoller
Involvement of CD44 in cytoskeleton rearrangement and raft reorganization in T cells
J. Cell Sci., January 3, 2001; 114(6): 1169 - 1178.
[Abstract] [PDF]


Home page
J. Immunol.Home page
T. Takahashi, M. Nieda, Y. Koezuka, A. Nicol, S. A. Porcelli, Y. Ishikawa, K. Tadokoro, H. Hirai, and T. Juji
Analysis of Human V{alpha}24+ CD4+ NKT Cells Activated by {alpha}-Glycosylceramide-Pulsed Monocyte-Derived Dendritic Cells
J. Immunol., May 1, 2000; 164(9): 4458 - 4464.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Q. Rafi-Janajreh, D. Chen, R. Schmits, T. W. Mak, R. L. Grayson, D. P. Sponenberg, M. Nagarkatti, and P. S. Nagarkatti
Evidence for the Involvement of CD44 in Endothelial Cell Injury and Induction of Vascular Leak Syndrome by IL-2
J. Immunol., August 1, 1999; 163(3): 1619 - 1627.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.